At first glance, I liked the new Clever Chek meter. It’s aesthetically pleasing and presented (packaged) very well.
Simple Diagnostics in Williston Park, New York, the sole North American distributor of Clever Chek brand products, launched the Clever Check here in August. TaiDoc Technology Corporation in Taipei, Taiwan, is the manufacturer.
The first genetic test available to determine a risk factor for type 2 diabetes recently became available. I just beta tested and discussed it with the company’s CEO and several other officials. DNA Direct, a privately funded company in San Francisco, offers the test of this gene that can lead to diabetes.
At the Children with Diabetes convention at DisneyWorld in July Dr. Irl Hirsch announced that a new Accu-Chek device is the first good way that we have to measure glycemic variability, because it incorporates new low and high blood glucose indices. It’s a big step forward, but the product’s developer tells me that what it offers is something else.
While I am vacationing in New Mexico, I combined a little business with pleasure by visiting VeraLight Inc. in Albuquerque on Friday. I wanted to check out their device that uses fluorescence to non-invasively measure advanced glycation end-products (AGEs) in the skin.
Expertise and extensive experience have an important place in information about diabetes. But first impressions count too. The experts can miss key experiences when they aren’t coming fresh to a topic.
This weekend I happened to sit down for breakfast at our local farmers’ market with a couple of young women. I noticed that one of them was checking her blood glucose with the original FreeStyle meter and couldn’t resist striking up a conversation with her.